A Controllable Chiral Molecular Machine: Movement on Molecular Level
(CDCl3, 400 MHz, δ): 7.34–6.98 (m, 21H), 6.82 (d, J = 8.4 Hz, 2H), was extracted with CH2Cl2 (3 × 30 mL). The organic layers were
6.73 (d, J = 8.6 Hz, 2H), 4.37 (m, 2H), 3.92 (t, J = 6.3 Hz, 4H), 3.29 combined, dried over Na2SO4, and concentrated to obtain the
(m, 4H), 1.92 (m, 2H), 1.85–1.70 (m, 2H), 1.69–1.57 (m, 3H), [3]rotaxane 4 (45 mg, 85%) as an orange solid. 1H NMR (CD3CN,
1.45 (m, 13H); 13C NMR (CDCl3, 100 MHz, δ): 158.3, 156.8, 147.1, 400 MHz, δ): 8.17 (d, J = 9.2 Hz, 2H), 8.00 (d, J = 8.4 Hz, 2H), 7.91
146.8, 139.0, 132.2, 131.2, 129.3, 127.5, 125.9, 114.5, 113.2, (s, 2H), 7.69 (d, J = 9.1 Hz, 2H), 7.43 (t, J = 7.3 Hz, 2H), 7.32–7.07
85.2, 79.7, 67.7, 64.3, 51.4, 29.2, 28.9, 28.5, 27.5, 26.6, 25.7; (m, 40H), 6.86–6.76 (m, 16H), 6.59 (m, 8H), 5.35 (d, J = 14.0 Hz,
MS (MALDI-TOF): m/z 747.5 [M+Na]; Anal. calcd for C46H52N4O4: C 2H), 5.24 (d, J = 14.0 Hz, 2H), 4.53–4.48 (m, 4H), 4.48–4.46
76.21, H 7.23, N 7.73; found: C 75.91, H 7.21, N 7.69.
(m, 2H), 4.32 (d, J = 3.1 Hz, 4H), 4.05 (m, 14H), 3.86–3.70
Compound 1: Trifluroacetic acid (1 mL) was added to the (m, 22H), 3.62 (m, 20H), 3.39 (m, 6H), 1.98 (m, 4H), 1.86–1.76
solution of compound 11 (1.5 g, 2 mmol) in CH2Cl2 (10 mL). The (m, 4H), 1.68–1.60 (m, 4H), 1.41 (m, 4H), 1.26 (d, J = 13.0 Hz,
mixture was stirred at room temperature overnight. The solvent 4H); 13C NMR (CD3CN, 100 MHz, δ): 160.3, 157.2, 153.6, 148.3,
was evaporated off and the residue was dissolved in a mixture 148.2, 140.2, 140.0, 134.2, 132.8, 131.9, 131.6, 131.1, 130.0,
of acetone and water. Then the aqueous of NH4PF6 (500 mg, 129.7, 128.6, 128.1, 126.9, 125.9, 125.5, 125.0, 122.2, 121.6,
3 mmol) was added. The mixture was stirred for 1 h and then the 115.1, 114.4, 113.4, 71.6, 71.1, 68.8, 68.3, 65.2, 60.6, 54.7,
acetone was evaporated off. The aqueous solution was extracted 52.7, 46.8, 38.3, 29.6, 27.3, 26.2, 25.9; MS (MALDI-TOF): m/z:
with CH2Cl2 several times. The collected organic layers were dried 2683.3 [M–3PF6]3+; Anal. calcd for C158H178F24N8O22P4: C, 60.80;
over Na2SO4, filtered, and concentrated in vacuo. The crude H, 5.75; N, 3.59. Found: C, 60.32; H, 5.71; N, 3.55.
product was purified by chromatography (SiO2: CH2Cl2/MeOH,
Compound 5: A mixture of compound 1 (385 mg, 0.50 mmol),
60:1) to afford compound 1 as a yellow solid (1.16g, 75%). 1H compound 2 (90 mg, 0.25 mmol), and [Cu(MeCN)4]PF6 (185 mg,
NMR (400 MHz, CDCl3, δ): 7.36 (d, J = 8.7 Hz, 2H), 7.31–7.24 0.5 mmol) was stirred in dry CH2Cl2 at room temperature under
(m, 12H), 7.21 (m, 6H), 6.95 (d, J = 8.7 Hz, 2H), 6.83 (d, J = nitrogen for 48 h. After removal of the solvent, the crude product
9.0 Hz, 2H), 4.11–4.05 (m, 4H), 4.00 (t, J = 6.5 Hz, 2H), 3.31 (t, J = was purified by column chromatography (SiO2: CH2Cl2/MeOH 30:1)
6.9 Hz, 2H), 3.17 (t, J = 6.7 Hz, 2H), 2.15–2.06 (m, 2H), 1.96 (m, to afford thread 5 (390 mg, 82%). 1H NMR (CD3CN, 400 MHz, δ):
3H), 1.82–1.73 (m, 2H), 1.68–1.56 (m, 2H), 1.53–1.38 (m, 4H); 8.01 (d, J = 9.1 Hz, 2H), 7.92 (d, J = 8.2 Hz, 2H), 7.59 (d, J = 9.1 Hz,
13C NMR (CDCl3, 100 MHz, δ): 161.4, 157.7, 148.6, 141.0, 133.3, 2H), 7.39–7.11 (m, 48H), 7.03 (d, J = 7.5 Hz, 4H), 6.87 (d, J = 8.4
132.9, 132.1, 129.1, 127.3, 124.4, 116.2, 114.8, 69.2, 67.0, Hz, 4H), 6.76 (d, J = 8.7 Hz, 4H), 5.06 (d, J = 5.5 Hz, 4H), 4.15
65.7, 52.6, 52.4, 47.2, 30.1, 29.8, 27.5, 27.0, 26.6; MS (MALDI- (d, J = 5.0 Hz, 4H), 4.00 (m, 8H), 3.89 (t, J = 6.4 Hz, 4H), 3.07 (t, J =
TOF): m/z 625.3 [M]; Anal. calcd for C41H45F6N4O2P: C 63.89, 6.8 Hz, 5H), 2.10–2.00 (m, 3H), 1.76–1.61 (m, 8H), 1.44–1.33
H 5.88, N 7.27; found: C 63.64, H 5.84, N 7.25.
(m, 4H), 1.16 (d, J = 7.4 Hz, 4H); 13C NMR (CD3CN, 100 MHz, δ):
Compound 3: A dilute mixture of 1 (77 mg, 0.1 mmol), 159.5, 156.4, 153.9, 147.2, 143.6, 139.5, 133.8, 131.8, 131.0,
DB24C8 (45 mg, 0.1 mmol), and [Cu(MeCN)4]PF6 (37 mg, 130.6, 129.4, 128.1, 127.6, 127.2, 126.5, 125.9, 124.9, 123.9,
0.1 mmol) was stirred in dry CH2Cl2 (100 mL) at room temperature 123.1, 120.2, 116.0, 114.7, 113.4, 67.6, 65.6, 64.3, 63.2, 51.4,
under nitrogen for 0.5 h, then a dilute solution of compound 2 49.7, 45.7, 29.5, 28.5, 26.3, 25.6, 24.9; MS (MALDI-TOF): m/z:
(18 mg, 0.05 mmol) in CH2Cl2 (30 mL) was added to the solution 1611.9 [M–H]+, 1633.9 [M–H+Na]+, 1673.9 [M–H+Na+K]+; Anal.
slowly over 2 h and stirred for another 48 h under nitrogen. After calcd for C108H108N8F12O6P2: C 68.13, H 5.72, N 5.89; found:
removal of the solvent, the crude product was purified by column C 67.62, H 5.69, N 5.86.
chromatography (CH2Cl2/MeOH 30:1) to afford [3]rotaxane 3
Compound 6: Compound 6 was synthesized by using the same
(78 mg, 56%). 1H NMR (CD3CN, 400 MHz, δ): 8.01 (d, J = 9.1 procedure as described for the preparation of compound 4. 1H
Hz, 2H), 7.91 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 9.1 Hz, 2H), 7.34 NMR (CD3CN, 400 MHz, δ): 8.17 (d, J = 8.9 Hz, 2H), 8.00 (d, J = 8.1
(m, 2H), 7.31–7.26 (m, 13H), 7.24 (m, 3H), 7.22–7.15 (m, 12H), Hz, 2H), 7.88 (s, 2H), 7.69 (d, J = 9.0 Hz, 2H), 7.47–7.13 (m, 46H),
7.08 (m, 8H), 7.00 (d, J = 8.5 Hz, 2H), 6.80 (s, 15H), 6.62–6.54 6.93 (d, J = 8.5 Hz, 3H), 6.79 (t, J = 8.9 Hz, 5H), 5.28 (dd, J = 48.4,
(m, 8H), 5.11 (d, J = 3.6 Hz, 4H), 4.52–4.44 (m, 4H), 4.16 (t, J = 14.1 Hz, 4H), 4.32 (m, 4H), 4.07 (m, 7H), 3.94 (t, J = 6.4 Hz, 4H),
7.0 Hz, 4H), 4.03 (m, 15H), 3.85–3.69 (m, 23H), 3.66–3.47 3.38 (s, 6H), 3.20 (t, J = 6.6 Hz, 4H), 1.81 (m, 4H), 1.69 (m, 4H),
(m, 20H), 1.99 (m, 3H), 1.77–1.66 (m, 4H), 1.65–1.55 (m, 4H), 1.43 (m, 4H), 1.27 (m, 8H); 13C NMR (CD3CN, 100 MHz, δ): 159.2,
1.42–1.32 (m, 4H), 1.18 (m, 4H); 13C NMR (CD3CN, 100 MHz, δ): 155.3, 151.7, 146.3, 138.8, 138.1, 132.3, 131.1, 130.7, 129.7,
161.1, 157.8, 155.4, 148.9, 148.8, 145.2, 140.9, 135.3, 133.4, 129.2, 128.1, 127.4, 126.7, 126.2, 125.0, 124.0, 123.5, 121.3,
132.5, 132.2, 131.0, 130.6, 129.6, 129.2, 128.0, 127.5, 126.4, 119.8, 113.9, 112.5, 66.8, 64.6, 64.3, 63.4, 58.7, 52.8, 50.1,
125.6, 125.5, 124.6, 122.8, 121.7, 117.5, 115.8, 115.0, 114.1, 44.9, 36.4, 27.7, 24.3, 24.0; ESI-MS: m/z: 411.1; Anal. calcd for
72.2, 71.7, 69.4, 69.0, 65.8, 64.8, 53.4, 51.2, 47.4, 31.2, 30.1,
C110H114N8F24O6P4: C 59.41, H 5.17, N 5.04; found: C 59.23, H
27.9, 27.2, 26.6; MS (MALDI-TOF): m/z: 2508.3 [M–H–2PF6]+; 5.15, N 5.02.
Anal. calcd for C156H172N8F12O22P2: C 66.89, H 6.19, N 4.00;
found: C 66.69, H 6.15, N 3.97.
Compound 4: [3]Rotaxane 3 (50 mg, 0.017 mmol) was dis-
solved in iodomethane (5 mL), and the mixture was stirred for
48 h at 40 °C. Then iodomethane was evaporated, and the solid
was washed with Et2O to give a red solid. Then, to a suspension
of the previous solid in H2O (10 mL) were added NH4PF6 (16.5 mg,
0.1 mmol) and CH2Cl2 (15 mL). The resulting bilayer solution was
vigorously stirred for 3 h. After separation, the aqueous layer
Supporting Information
Supporting Information is available from the Wiley Online Library
or from the author.
small 2012,
DOI: 10.1002/smll.201200670
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5